Follow
Thierry Roumeguere
Thierry Roumeguere
Verified email at ulb.ac.be
Title
Cited by
Cited by
Year
Extraperitoneal laparoscopic radical prostatectomy
R Bollens, MV Bossche, T Roumeguere, A Damoun, S Ekane, ...
European urology 40 (1), 65-69, 2001
3622001
Erectile dysfunction is associated with a high prevalence of hyperlipidemia and coronary heart disease risk
TH Roumeguere, E Wespes, Y Carpentier, P Hoffmann, CC Schulman
European urology 44 (3), 355-359, 2003
3072003
Trans-obturator vaginal tape (TOT®) for female stress incontinence: one year follow-up in 120 patients
T Roumeguère, TH Quackels, R Bollens, A De Groote, A Zlotta, ...
European urology 48 (5), 805-809, 2005
2012005
Radical prostatectomy: a prospective comparison of oncological and functional results between open and laparoscopic approaches
T Roumeguere, R Bollens, M Vanden Bossche, D Rochet, D Bialek, ...
World Journal of Urology 20 (6), 360-366, 2003
1922003
Late onset of bladder urothelial carcinoma after kidney transplantation for end-stage aristolochic acid nephropathy: a case series with 15-year follow-up
A Lemy, KM Wissing, S Rorive, A Zlotta, T Roumeguere, MCM Martinez, ...
American Journal of Kidney Diseases 51 (3), 471-477, 2008
1092008
Laparoscopic partial nephrectomy with “on-demand” clamping reduces warm ischemia time
R Bollens, A Rosenblatt, BP Espinoza, A De Groote, T Quackels, ...
european urology 52 (3), 804-810, 2007
1072007
Low-density lipoprotein modified by myeloperoxidase in inflammatory pathways and clinical studies
C Delporte, P Van Antwerpen, L Vanhamme, T Roumeguère, ...
Mediators of inflammation 2013, 2013
1032013
Is one set of sextant biopsies enough to rule out prostate cancer? Influence of transition and total prostate volumes on prostate cancer yield
B Djavan, AR Zlotta, S Ekane, M Remzi, G Kramer, T Roumeguere, ...
European urology 38 (2), 218-224, 2000
1022000
Laparoscopic radical prostatectomy: the learning curve
R Bollens, S Sandhu, T Roumeguere, T Quackels, C Schulman
Current opinion in urology 15 (2), 79-82, 2005
862005
Use of statins and outcome of BCG treatment for bladder cancer
P Hoffmann, T Roumeguère, C Schulman, R Van Velthoven
New England Journal of Medicine 355 (25), 2705-2707, 2006
622006
COVID-19 and the male susceptibility: the role of ACE2, TMPRSS2 and the androgen receptor
G Mjaess, A Karam, F Aoun, S Albisinni, T Roumeguère
Progrès en urologie 30 (10), 484-487, 2020
582020
Select screening in a specific high-risk population of patients suggests a stage migration toward detection of non–muscle-invasive bladder cancer
AR Zlotta, T Roumeguere, C Kuk, S Alkhateeb, S Rorive, A Lemy, ...
European urology 59 (6), 1026-1031, 2011
582011
Silodosin in the treatment of benign prostatic hyperplasia
M Rossi, T Roumeguère
Drug design, development and therapy 4, 291, 2010
552010
Is seminal vesicle ablation mandatory for all patients undergoing radical prostatectomy?: A multivariate analysis on 1283 patients
AR Zlotta, T Roumeguère, V Ravery, P Hoffmann, F Montorsi, L Türkeri, ...
European urology 46 (1), 42-49, 2004
552004
Androgen deprivation therapy in castrate-resistant prostate cancer: how important is GnRH agonist backbone therapy?
AS Merseburger, P Hammerer, F Rozet, T Roumeguère, O Caffo, ...
World journal of urology 33 (8), 1079-1085, 2015
522015
The place of surgery for vascular impotence in the third millennium
E Wespes, T Wildschutz, T Roumeguere, CC Schulman
The Journal of urology 170 (4), 1284-1286, 2003
512003
The importance of measuring the prostatic transition zone: an anatomical and radiological study
AR Zlotta, B Djavan, M Damoun, T Roumeguere, M Petein, K Entezari, ...
BJU international 84, 661-666, 1999
481999
Urgency and other lower urinary tract symptoms in men aged≥ 40 years: a Belgian epidemiological survey using the ICIQ‐MLUTS questionnaire
D De Ridder, T Roumeguere, L Kaufman
International journal of clinical practice 69 (3), 358-365, 2015
422015
Current management of erectile dysfunction after cancer treatment
A Peltier, R Van Velthoven, T Roumeguère
Current Opinion in Oncology 21 (4), 303-309, 2009
422009
Long-term prognostic value of the combination of EORTC risk group calculator and molecular markers in non-muscle-invasive bladder cancer patients treated with intravesical …
SS Alkhateeb, M Neill, S Bar-Moshe, B Van Rhijn, DM Kakiashvili, ...
Urology annals 3 (3), 119, 2011
402011
The system can't perform the operation now. Try again later.
Articles 1–20